|
US5118800A
(en)
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
Oligonucleotides possessing a primary amino group in the terminal nucleotide
|
|
FR2567892B1
(fr)
|
1984-07-19 |
1989-02-17 |
Centre Nat Rech Scient |
Nouveaux oligonucleotides, leur procede de preparation et leurs applications comme mediateurs dans le developpement des effets des interferons
|
|
US5185444A
(en)
|
1985-03-15 |
1993-02-09 |
Anti-Gene Deveopment Group |
Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
|
|
US5166315A
(en)
|
1989-12-20 |
1992-11-24 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
US5591722A
(en)
|
1989-09-15 |
1997-01-07 |
Southern Research Institute |
2'-deoxy-4'-thioribonucleosides and their antiviral activity
|
|
AU658562B2
(en)
|
1989-10-24 |
1995-04-27 |
Isis Pharmaceuticals, Inc. |
2' modified oligonucleotides
|
|
US5646265A
(en)
|
1990-01-11 |
1997-07-08 |
Isis Pharmceuticals, Inc. |
Process for the preparation of 2'-O-alkyl purine phosphoramidites
|
|
US5670633A
(en)
|
1990-01-11 |
1997-09-23 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides that detect and modulate gene expression
|
|
GB9009980D0
(en)
|
1990-05-03 |
1990-06-27 |
Amersham Int Plc |
Phosphoramidite derivatives,their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides
|
|
ES2116977T3
(es)
|
1990-05-11 |
1998-08-01 |
Microprobe Corp |
Soportes solidos para ensayos de hibridacion de acidos nucleicos y metodos para inmovilizar oligonucleotidos de modo covalente.
|
|
US6582908B2
(en)
|
1990-12-06 |
2003-06-24 |
Affymetrix, Inc. |
Oligonucleotides
|
|
EP0538194B1
(de)
|
1991-10-17 |
1997-06-04 |
Novartis AG |
Bicyclische Nukleoside, Oligonukleotide, Verfahren zu deren Herstellung und Zwischenprodukte
|
|
US5359044A
(en)
|
1991-12-13 |
1994-10-25 |
Isis Pharmaceuticals |
Cyclobutyl oligonucleotide surrogates
|
|
EP0618925B2
(en)
|
1991-12-24 |
2012-04-18 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides
|
|
FR2687679B1
(fr)
|
1992-02-05 |
1994-10-28 |
Centre Nat Rech Scient |
Oligothionucleotides.
|
|
EP0577558A2
(de)
|
1992-07-01 |
1994-01-05 |
Ciba-Geigy Ag |
Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte
|
|
DK0691968T3
(da)
|
1993-03-30 |
1998-02-23 |
Sanofi Sa |
Acykliske nukleosid-analoge og oligonukleotidsekvenser indeholdende disse
|
|
US5801154A
(en)
|
1993-10-18 |
1998-09-01 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of multidrug resistance-associated protein
|
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
|
US5627053A
(en)
|
1994-03-29 |
1997-05-06 |
Ribozyme Pharmaceuticals, Inc. |
2'deoxy-2'-alkylnucleotide containing nucleic acid
|
|
US5597909A
(en)
|
1994-08-25 |
1997-01-28 |
Chiron Corporation |
Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
|
|
US5681940A
(en)
*
|
1994-11-02 |
1997-10-28 |
Icn Pharmaceuticals |
Sugar modified nucleosides and oligonucleotides
|
|
US7875733B2
(en)
|
2003-09-18 |
2011-01-25 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
|
|
US6770748B2
(en)
|
1997-03-07 |
2004-08-03 |
Takeshi Imanishi |
Bicyclonucleoside and oligonucleotide analogue
|
|
JP3756313B2
(ja)
|
1997-03-07 |
2006-03-15 |
武 今西 |
新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
|
|
DE69829760T3
(de)
|
1997-09-12 |
2016-04-14 |
Exiqon A/S |
Bi- und tri-zyklische - nukleosid, nukleotid und oligonukleotid-analoga
|
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
|
US20030228597A1
(en)
|
1998-04-13 |
2003-12-11 |
Cowsert Lex M. |
Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation
|
|
US6043352A
(en)
|
1998-08-07 |
2000-03-28 |
Isis Pharmaceuticals, Inc. |
2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides
|
|
US5998148A
(en)
|
1999-04-08 |
1999-12-07 |
Isis Pharmaceuticals Inc. |
Antisense modulation of microtubule-associated protein 4 expression
|
|
JP2002543214A
(ja)
|
1999-05-04 |
2002-12-17 |
エクシコン エ／エス |
Ｌ−リボ−ｌｎａ類縁体
|
|
US6525191B1
(en)
|
1999-05-11 |
2003-02-25 |
Kanda S. Ramasamy |
Conformationally constrained L-nucleosides
|
|
WO2001049687A2
(en)
|
1999-12-30 |
2001-07-12 |
K. U. Leuven Research & Development |
Cyclohexene nucleic acids
|
|
USH2191H1
(en)
|
2000-10-24 |
2007-06-05 |
Snp Consortium |
Identification and mapping of single nucleotide polymorphisms in the human genome
|
|
US20050019915A1
(en)
|
2001-06-21 |
2005-01-27 |
Bennett C. Frank |
Antisense modulation of superoxide dismutase 1, soluble expression
|
|
WO2003004602A2
(en)
|
2001-07-03 |
2003-01-16 |
Isis Pharmaceuticals, Inc. |
Nuclease resistant chimeric oligonucleotides
|
|
WO2004044139A2
(en)
|
2002-11-05 |
2004-05-27 |
Isis Parmaceuticals, Inc. |
Modified oligonucleotides for use in rna interference
|
|
WO2004041889A2
(en)
|
2002-11-05 |
2004-05-21 |
Isis Pharmaceuticals, Inc. |
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
|
DK2284266T3
(da)
|
2002-11-14 |
2014-01-13 |
Thermo Fisher Scient Biosciences Inc |
sIRNA-MOLEKYLE MOD TP53
|
|
US7250496B2
(en)
|
2002-11-14 |
2007-07-31 |
Rosetta Genomics Ltd. |
Bioinformatically detectable group of novel regulatory genes and uses thereof
|
|
US7790867B2
(en)
|
2002-12-05 |
2010-09-07 |
Rosetta Genomics Inc. |
Vaccinia virus-related nucleic acids and microRNA
|
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
|
DK1661905T3
(da)
|
2003-08-28 |
2012-07-23 |
Takeshi Imanishi |
Hidtil ukendte syntetiske nukleinsyrer af N-O-krydsbindingstype
|
|
US20050261233A1
(en)
|
2004-04-21 |
2005-11-24 |
Sanjay Bhanot |
Modulation of glucose-6-phosphatase translocase expression
|
|
WO2005116204A1
(ja)
|
2004-05-11 |
2005-12-08 |
Rnai Co., Ltd. |
Ｒｎａ干渉を生じさせるポリヌクレオチド、および、これを用いた遺伝子発現抑制方法
|
|
EP1766052A4
(en)
|
2004-06-03 |
2009-12-16 |
Isis Pharmaceuticals Inc |
OLIGOMERIC CHIMERIC COMPOSITIONS WITH BRECH
|
|
WO2005121372A2
(en)
|
2004-06-03 |
2005-12-22 |
Isis Pharmaceuticals, Inc. |
Double strand compositions comprising differentially modified strands for use in gene modulation
|
|
WO2006047842A2
(en)
|
2004-11-08 |
2006-05-11 |
K.U. Leuven Research And Development |
Modified nucleosides for rna interference
|
|
WO2007089611A2
(en)
|
2006-01-26 |
2007-08-09 |
Isis Pharmaceuticals Inc. |
Compositions and their uses directed to huntingtin
|
|
US7399845B2
(en)
|
2006-01-27 |
2008-07-15 |
Isis Pharmaceuticals, Inc. |
6-modified bicyclic nucleic acid analogs
|
|
JP5825754B2
(ja)
|
2006-05-05 |
2015-12-02 |
アイシス ファーマシューティカルズ， インコーポレーテッド |
Ａｐｏｂの発現を調節するための化合物および方法
|
|
CN101490074B
(zh)
|
2006-05-11 |
2013-06-26 |
Isis制药公司 |
5’-修饰的双环核酸类似物
|
|
US20100216864A1
(en)
|
2006-10-09 |
2010-08-26 |
Ellen Marie Straarup |
RNA Antagonist Compounds for the Modulation of PCSK9
|
|
EA201101361A1
(ru)
|
2006-12-14 |
2012-11-30 |
Новартис Аг |
Композиции и способы, предназначенные для лечения мышечных и сердечно-сосудистых нарушений
|
|
US20100190837A1
(en)
|
2007-02-15 |
2010-07-29 |
Isis Pharmaceuticals, Inc. |
5'-Substituted-2-F' Modified Nucleosides and Oligomeric Compounds Prepared Therefrom
|
|
DK2170917T3
(da)
|
2007-05-30 |
2012-10-08 |
Isis Pharmaceuticals Inc |
N-Substituerede bicycliske nukleinsyreanaloge med aminomethylenbro
|
|
ES2386492T3
(es)
|
2007-06-08 |
2012-08-21 |
Isis Pharmaceuticals, Inc. |
Análogos de ácidos nucleicos bicíclicos carbocíclicos
|
|
EP2014769B1
(en)
|
2007-06-18 |
2010-03-31 |
Commissariat à l'Energie Atomique |
Reversible siRNAa-based silencing of mutated and endogenous wild-type huntingtin gene and its application for the treatment of Huntington's disease
|
|
ATE538127T1
(de)
|
2007-07-05 |
2012-01-15 |
Isis Pharmaceuticals Inc |
6-disubstituierte bicyclische nukleinsäureanaloga
|
|
US20090123928A1
(en)
|
2007-10-11 |
2009-05-14 |
The Johns Hopkins University |
Genomic Landscapes of Human Breast and Colorectal Cancers
|
|
US20110152346A1
(en)
*
|
2007-11-05 |
2011-06-23 |
Baltic Technology Development Ltd. |
Use of Oligonucleotides with Modified Bases in Hybridization of Nucleic Acids
|
|
WO2009067647A1
(en)
|
2007-11-21 |
2009-05-28 |
Isis Pharmaceuticals, Inc. |
Carbocyclic alpha-l-bicyclic nucleic acid analogs
|
|
US8530640B2
(en)
|
2008-02-07 |
2013-09-10 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexitol nucleic acid analogs
|
|
DK2356129T3
(da)
|
2008-09-24 |
2013-05-13 |
Isis Pharmaceuticals Inc |
Substituerede alpha-L-bicykliske nukleosider
|
|
DK2361256T3
(da)
|
2008-09-24 |
2013-07-01 |
Isis Pharmaceuticals Inc |
Cyclohexenyl-nukleinsyreanaloger
|
|
WO2010120820A1
(en)
|
2009-04-13 |
2010-10-21 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for modulation of smn2 splicing
|
|
EP2419146A4
(en)
*
|
2009-04-15 |
2013-11-27 |
Isis Pharmaceuticals Inc |
MODULATION OF IGNITION REACTIONS BY FACTOR XI
|
|
EA201270019A1
(ru)
|
2009-06-15 |
2012-06-29 |
Элнилэм Фармасьютикалз, Инк. |
Двуцепочечная рнк, включенная в липидный состав и мишенью которой является ген pcsk9
|
|
US20140004565A1
(en)
|
2009-07-06 |
2014-01-02 |
Alnylam Pharmaceuticals, Inc. |
Cell-based bioprocessing
|
|
US8927513B2
(en)
|
2009-07-07 |
2015-01-06 |
Alnylam Pharmaceuticals, Inc. |
5′ phosphate mimics
|
|
US9012421B2
(en)
|
2009-08-06 |
2015-04-21 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexose nucleic acid analogs
|
|
WO2011135396A1
(en)
|
2010-04-30 |
2011-11-03 |
Cellectis |
Method for modulating double-strand break-induced homologous recombination
|
|
WO2012005898A2
(en)
|
2010-06-15 |
2012-01-12 |
Alnylam Pharmaceuticals, Inc. |
Chinese hamster ovary (cho) cell transcriptome, corresponding sirnas and uses thereof
|
|
CN103167883B
(zh)
*
|
2010-07-19 |
2016-08-03 |
F·C·贝内特 |
肌强直性营养障碍蛋白激酶(dmpk)表达的调节
|
|
EP2640853B1
(en)
*
|
2010-11-17 |
2018-12-26 |
Ionis Pharmaceuticals, Inc. |
Modulation of alpha synuclein expression
|
|
DK2655621T3
(en)
|
2010-12-20 |
2018-08-13 |
Massachusetts Gen Hospital |
Polycomb-associated non-coding RNAS
|
|
WO2012092367A1
(en)
|
2010-12-28 |
2012-07-05 |
University Of Rochester |
Nucleic acid binding compounds, methods of making, and use thereof
|
|
EP2697243B1
(en)
*
|
2011-04-01 |
2018-10-31 |
Ionis Pharmaceuticals, Inc. |
Modulation of signal transducer and activator of transcription 3 (stat3) expression
|
|
EP3505528B1
(en)
*
|
2011-04-21 |
2020-11-25 |
Ionis Pharmaceuticals, Inc. |
Modulation of hepatitis b virus (hbv) expression
|
|
DK2751284T3
(en)
*
|
2011-08-31 |
2017-03-27 |
Univ Manchester |
PROCEDURE FOR DIAGNOSTICING A NEURODEGENERATIVE DISEASE
|
|
WO2013036833A1
(en)
|
2011-09-09 |
2013-03-14 |
Mayo Foundation For Medical Education And Research |
Detecting frontotemporal dementia and amyotrophic lateral sclerosis
|
|
HK1201555A1
(en)
*
|
2011-10-25 |
2015-09-04 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of gccr expression
|
|
JP2014533508A
(ja)
*
|
2011-11-17 |
2014-12-15 |
リーアニクス・インコーポレイテッドＲｈｅｏｎｉｘ， Ｉｎｃ． |
選択的分子分析のためのシステムおよび方法
|
|
US10066228B2
(en)
|
2011-11-30 |
2018-09-04 |
Sarepta Therapeutics, Inc. |
Oligonucleotides for treating expanded repeat diseases
|
|
WO2013086207A1
(en)
|
2011-12-06 |
2013-06-13 |
The Ohio State University |
Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease
|
|
EP3228712A1
(en)
*
|
2012-04-23 |
2017-10-11 |
BioMarin Technologies B.V. |
Rna modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
|
|
CN108359668A
(zh)
*
|
2012-05-24 |
2018-08-03 |
Ionis制药公司 |
用于调节载脂蛋白(a)表达的方法和组合物
|
|
EP2906697A4
(en)
*
|
2012-10-15 |
2016-06-22 |
Ionis Pharmaceuticals Inc |
METHOD FOR MONITORING THE C9ORF72 EXPRESSION
|
|
WO2014062691A2
(en)
|
2012-10-15 |
2014-04-24 |
Isis Pharmaceuticals, Inc. |
Compositions for modulating c9orf72 expression
|
|
DK2906696T4
(da)
|
2012-10-15 |
2023-02-27 |
Ionis Pharmaceuticals Inc |
Fremgangsmåder til modulering af c9orf72-ekspression
|
|
HUE046434T2
(hu)
*
|
2013-01-22 |
2020-03-30 |
Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E V |
Dipeptid-ismétlõdõ fehérjék terápiás célpontként neurodegeneratív betegségekben, hexanukleotid ismétlõdõ expanzióval
|
|
EP3055414A4
(en)
*
|
2013-10-11 |
2017-07-19 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating c9orf72 expression
|
|
WO2016024205A1
(en)
|
2014-08-15 |
2016-02-18 |
Pfizer Inc. |
Oligomers targeting hexanucleotide repeat expansion in human c9orf72 gene
|
|
US10538762B2
(en)
|
2014-10-14 |
2020-01-21 |
The Board Of Regents Of The University Of Texas System |
Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAS targeting the expanded hexanucleotide repeat
|
|
US11260073B2
(en)
|
2015-11-02 |
2022-03-01 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulating C90RF72
|
|
WO2017180835A1
(en)
|
2016-04-13 |
2017-10-19 |
Ionis Pharmaceuticals, Inc. |
Methods for reducing c9orf72 expression
|
|
US10399845B2
(en)
|
2017-09-22 |
2019-09-03 |
Emco Wheaton Retail Corporation |
Testable overfill prevention valve for a liquid storage container
|